Seb Jantet

Seb Jantet joined DrugDev in August 2013 as CFO after a 22-year stint working in “the City.” Seb brings to DrugDev a wealth of financial experience, a strong commercial mind and pragmatic “can do” attitude. A long-time member of the Securities Institute, he has been instrumental in putting into place robust financial reporting systems throughout the group and introducing an element of financial rigor.


Seb started his career at KPMG, spending eight years in a variety of roles in both audit and corporate finance. He then moved to Granville Baird as an equity analyst covering the technology sector. Prior to joining DrugDev, Seb spent 11 years at Investec where he was consistently ranked as a top three UK Healthcare analyst. He was involved in multiple equity raises and IPOs, helping to raise $1bn for clients.


A fluent French speaker, Seb is based in London and when not at work can be found ferrying his four children between parties, sport clubs and the myriad of other actives demanded of today’s youth. He is a passionate skier and, for his sins, a supporter of Fulham Football Club.